Informatietype:
Webinar
Thema:
Metabolic and immune health
1 episode

In vitro microbiome and ex vivo intestinal models for gut health

Watch the webinar where we introduce our latest developments in in vitro models for the study of gut microbiota dynamics and host intestinal tissue response.

Microbiome modulation and activity, and intestinal wall function

Gut health is a key factor in our overall health and well-being. The gut microbiome that inhabits the digestive environment of the gut lumen contributes to intestinal homeostasis. Food products, drugs, probiotics and other factors can influence the function of the gut wall and/or microbiome.

Our translational models can be used to study the impact of your product on gut microbiota and host tissue response and can help to evaluate and boost product innovation at an early stage. Our in vitro and ex vivo gut model systems provide the unique opportunity to screen different lead compounds, ingredients and solutions for specific target populations (obese, elderly, infants) and evaluate their potential to promote health.

Get inspired

7 resultaten, getoond 1 t/m 5

TNO's view of 2030: 50% reduction in lifestyle-related diseases

Informatietype:
Insight
14 November 2022

We look ahead to 2030 and find out, among other things, how we can offer people a healthy environment and with a healthier lifestyle.

Lifestyle related diseases

Informatietype:
Article

Behavioural change is the key to curing lifestyle diseases. In short: lifestyle as medicine. Find out more about our innovations and tools.

Chronic inflammatory diseases

Informatietype:
Article

Inflammatory balances are strongly influenced by extrinsic factors and modulation of these factors is key in fighting  inflammatory diseases.

Metabolic and immune health

Informatietype:
Article

We develop methods that enable the effects of nutrition on personal health to be measurable.

Translational models TNO excel in preclinical research

Informatietype:
Insight
13 June 2022
TNO’s animal models for NAFLD/NASH are the most translational to human tissue data in a recent Hepatology article about NAFLD/NASH and cardiovascular disease.